Approval · Notice of Compliance 30833 · 2023
ACID CONTROLLER MAXIMUM STRENGTH: Notice of Compliance 30833
Issued May 26, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30833
- Date
- May 26, 2023
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- MAXIMUM STRENGTH PEPCID AC
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID CONTROLLER MAXIMUM STRENGTH | 02538350 | Marketed |
Medicinal ingredients
- FAMOTIDINE 20 MG per TAB